Aims The mitochondrially expressed manganese-dependent superoxide dismutase (MnSOD, SOD2) is an essential antioxidative enzyme that is necessary for normal heart function. In this study, we investigated the heart function of mice that were exposed to increased oxidative stress for time periods of up to 6 months due to decreased MnSOD activity caused by heterozygous deletion of the MnSOD gene.
Aims The mitochondrially expressed manganese-dependent superoxide dismutase (MnSOD, SOD2) is an essential antioxidative enzyme that is necessary for normal heart function. In this study, we investigated the heart function of mice that were exposed to increased oxidative stress for time periods of up to 6 months due to decreased MnSOD activity caused by heterozygous deletion of the MnSOD gene.
Methods and results
We generated a mouse strain in which the gene encoding MnSOD was exchanged against a cassette containing the SOD cDNA under the control of the tetracycline response element. After breeding with mice carrying the tetracycline receptor, compound mice express MnSOD depending on the presence of tetracycline. Without tetracycline receptor the MnSOD gene is fully inactivated, and animals show an MnSOD-deficient phenotype. Using echocardiographic recordings, we found an impairment of left ventricular functions: MnSOD þ/2 mice displayed a decrease in fraction shortening and ejection fraction and an increase in left ventricular internal diameter in systole. Furthermore, MnSOD þ/2 mice developed heart hypertrophy with accompanying fibrosis and necrosis revealed by immunhistochemical analysis. Although we did not find an increase in apoptosis in MnSOD þ/2 hearts under normal conditions, we observed an increase of the number of apoptotic cells and vascular senescence after treatment with doxorubicin. Conclusion Our study demonstrates that lifelong reduction of MnSOD activity has a negative effect on normal heart function. This animal model presents a valuable tool to investigate the mechanism of heart pathology reported in patients bearing different polymorphic variants of the MnSOD gene and to develop new therapeutic strategies through manipulation of the antioxidative defence system.
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Introduction
Manganese-dependent superoxide dismutase (MnSOD) is the first enzyme of the mitochondrial antioxidative defence system, which diminishes the superoxide concentration and helps to prevent the formation of further oxygen radicals. It dismutates the superoxide anion arising as a by-product of oxidative phosphorylation. The product of MnSOD reaction, hydrogen peroxide, is further neutralized by additional mitochondrial antioxidative enzymes, mainly catalase and glutathione peroxidase.
MnSOD is essential for the survival of mice since its inactivation leads to early postnatal lethality as previously shown by two independent mouse MnSOD knockout strains. 1, 2 This feature distinguishes MnSOD from the cytosolic copper zinc SOD1 and the extracellular SOD3. Depending on the genetic background and technical differences in the construction of individual knockout strain, the survival rate of MnSOD mutants varies from day 15 of gestation up to 3 weeks after birth. [1] [2] [3] [4] The cause of death of MnSOD deficient mice remains unclear. Although failure of multiple organ systems, mainly the heart and the central nervous system as well as metabolic acidosis have been discussed, a definitive answer is still missing. 1, 2, 5 In contrast to homozygous MnSOD deficient mice, heterozygous mice (MnSOD þ/2 ) are viable and do not show any gross abnormalities despite of a 30-80% reduction of MnSOD activity and apparent lack of compensatory up-regulation of other antioxidative enzymes. 6 Remarkably, the mean and maximal lifespan of MnSOD þ/2 mice seems to remain unaffected, thus questioning the increased oxidative stress as a primary cause of aging. Significantly, the lifelong reduction of MnSOD activity leads to a higher cancer incidence in MnSOD þ/2 mice. 7 The negative influence of oxidative stress on heart performance and aging has been discussed extensively (reviewed in [8] [9] [10] [11] ) but clear evidence for adverse effects of a lifelong exposure to oxidative stress and its impact on heart function in vivo is still lacking. Previously, a substantial loss of MnSOD activity with age was discussed as a critical component of cardiac and vascular aging. [12] [13] [14] Similarly, conditional inactivation of the MnSOD gene in heart and skeletal muscle resulted in congestive heart failure and death at the mean age of 15 weeks. 15 Although these findings clearly document the importance of oxidative defence for the normal heart function, a complete MnSOD deficiency in the heart tissue does not reflect physiological situations and possible clinical settings. Since a partial MnSOD deficiency due to polymorphisms within the MnSOD gene in human patients affects cardiovascular homeostasis, 16, 17 we decided to generate a transgenic mouse strain in which the expression of MnSOD is controlled by exogenously administered doxycyclin. We found that a reduction of MnSOD activity by only 15-30% resulted in an impaired function of the heart, which was accompanied by heart hypertrophy, enhanced fibrosis, and necrosis of the myocardium.
Materials and methods

Materials
All biochemicals and culture media were purchased from Sigma-Aldrich Germany unless otherwise stated.
Generation of the targeting construct and of transgenic animals
The details of construct generation and genotyping of transgenic animals are given in Supplementary material online. All animal experiments were done in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Western blot
Western blots were performed according to standard procedures. Details are included in Supplementary material online.
Apoptosis
Apoptotic cells were visualized by terminal transferase dUTP nick end labelling (TUNEL) method. Deparafinized and permeabilized tissue sections were stained for apoptosis induced DNA fragmentation according to manufacturer's protocol (Roche). Hoechst counter-staining was used to visualize nuclei. In addition, the expression level of caspase 3 was estimated by real-time PCR; primer sequences are available on request.
In situ hybridization
In situ hybridization was performed using DIG-dUTP-labelled riboprobes on deparafinized sections as previously described. 18 
Measurement of activities of antioxidant enzymes
Inhibition of cytochrome c reduction method was used to determine activities of superoxide dismutases. 19 Catalase activity was measured as the rate of hydrogen peroxide decomposition. Glutathione peroxidase activity was determined by the so-called indirect procedure. Further details are described in Supplementary material online.
Echocardiography
Blinded studies were done in mice, which were anesthetized with 1.5% isoflurane. Echocardiography was performed as described previously; details are included in Supplementary material online.
Immunocytochemistry
Immunocytochemical detection was performed according to standard protocols. The following antibodies were used: monoclonal anti-myc-tag (Hybridoma Bank, dilution 1:1000), anti-MnSOD antibody (Sressgen), monoclonal anti-plakoglobin antibody, clone 15F11 (Sigma), collagen VI antibody (Rockland); secondary antibody: anti-rabit mouse Alexa 594, dilution 1:1000.
Treatment with doxorubicin and manganese (III) tetrakis (4-benzoic acid) porphyrin
The age of 4.5-month-old mice were anesthetized by intraperitoneal injections of Avertin. A solution of 1.25% Avertin was used at 0.025 mL/g of body weight. Then mini-osmotic pumps (Alzet, model 2002) filled with 2 mg/mL Doxorubicin (Sigma) in PBS were implanted subcutaneously on a dorsal side of animals. A dose of 15 mg/kg was administered over 2 weeks. Animals were sacrificed at the end of the second week. MnTBAP was injected daily (IP) at a dosis of 10 mg/kg for the time period of 4 weeks. MnTBAP injections were started 2 weeks prior to doxorubicin treatment.
Senescence-associated b-galactosidase staining
Organs were excised, washed in ice-cold PBS, and immediately embedded in Polyfreeze TM Tissue freezing medium TM . Cryosections (40 mm thick) were fixed in 4% PFA, washed in PBS, and subjected to senescence-associated b-galactosidase (SA-b-Gal) staining. SA-b-Gal staining was performed essentially as described by Dimri et al. 20 The SA-b-Gal staining solution contained 40 mM sodium phosphate pH 6.0, 5 mM potassium ferrocyanide, 5 mM Kferricyanide, 150 mM NaCl, and 4 mg/mL X-gal. Sections were stained for 48 h at 378C in the dark.
Real-time polymerase chain reaction analysis
Tissue RNA was isolated using the Trizol method and qRT-PCR performed as described. 21 Sequences for primer sets and further details are available from the authors on request.
Results
Generation of transgenic mice with a tetracycline-regulated MnSOD gene
Previous animal models of MnSOD deficiency were based on the inactivation of the MnSOD gene by constitutive or Cre recombinase-dependent recombination.
1,2,15, 22 We have generated a mouse strain that allows successive rounds of inactivation and activation of MnSOD expression. The system is based on the replacement of the endogenous MnSOD gene including the promoter region by a fragment that contains the MnSOD coding region (MnSOD cDNA) under the control of the tetracycline responsive element (TRE). After binding of TRE by a tetracycline regulator (TRT), the gene can be switched on or off depending on presence of the antibiotic tetracycline (or doxycycline) and TRT variants. The MnSOD gene structure and the targeted locus are schematically presented in Figure 1A . Details of the targeting and generation of transgenic TRE/SOD animals are described in Materials and methods section and in Supplementary material online. Successful targeting was confirmed using genomic DNA isolated from genetically modified mice by PCR and Southern blotting ( Figure 1B and C) . Western blot analysis proved the complete lack of the MnSOD protein in cells isolated from TRE/SOD homozygous animals ( Figure 1E ). We also confirmed the lack of MnSOD protein in different tissues isolated from newborn (P3) TRE/SOD homozygous animals (data not shown). Heterozygous TRE/ SOD mice showed a reduction of the expression of MnSOD protein between 15 and 30% when compared with wild-type controls ( Figure 1F ). We reasoned that the variability in the expression of MnSOD might be due to differences in the compensatory activation of the wild-type allele (see below). Homozygous mutant TRE/SOD mice, which lack any expression of MnSOD showed a decreased body size and weight, lower locomotoric activity and disturbed body balance ( Figure 1D , and data not shown). All homozygous mutants died within 1-3 weeks postnatally confirming previous reports. 1, 2, 15, 22 Heterozygous TRE/SOD mice were viable and fertile and did not show a significant reduction of their lifespan (data not shown). To definitely prove the functionality of the tetracycline-dependent regulation, the TRE/SOD mice were crossed with an a-myosin heavy chain (aMHC)-tTA mouse strain bearing the tet-off version of the tetracycline receptor (tTA) under the control of the aMHC gene promoter. Double heterozygous animals expressed the transgenic TRE/SOD allele exclusively within the myocardium ( Figure 1G and H and data not shown). Subsequent administration of doxycycline in drinking water at the concentration of 0.2% for a period of 2 weeks completely prevented expression of TRE/SOD mRNA and protein in the myocardium as demonstrated by northern and western blot analyses ( Figure 1G and H, respectively). Owing to the absence of tTA in all other tissues except the myocardium, the TRE/SOD allele was not expressed in any other tissues tested with or without doxycycline administration (data not shown). These results clearly demonstrate that the expression of the TRE/SOD allele is completely dependent on the tetracycline receptor.
3.2. Increased levels of apoptosis and atrial natriuretic factor expression in manganese-dependent superoxide dismutase deficient heart So far, we have been unable to achieve wild-type expression levels of MnSOD in all tissues using the TRE/SOD allele due to the lack of TRT mice, which truly expresses TRT in all tissues (unpublished results). We therefore decided to use TRE/SOD mice lacking any additional TRT gene to analyse changes in heart morphology and function that occur due to partial or complete MnSOD deficiency. First, we investigated, whether apoptosis and degenerative changes were present in newborn MnSOD 2/2 hearts, since controversial findings have been reported previously. 15, 23 Hearts from 3-day-old homozygous TRE/SOD animals were investigated for presence of apoptotic cells using TUNEL assay on paraffin sections. A significant increase in the accumulation of TUNEL-positive apoptotic cells was observed in MnSOD 2/2 cardiomyocytes, although this accumulation was restricted only to superficial layers of the heart wall of the left ventricle. No apoptotic cells were found in the deeper myocardium of MnSOD deficient and control hearts (Figure 2A and  B) . Higher level of apoptosis was confirmed by significant increase in caspase 3 expression ( Figure 2C) . Next, we analysed the expression of atrial natriuretic factor (ANF), since increased ANF expression indicates degenerative changes within the myocardium. [24] [25] [26] Figure 2D depicts representative sections from MnSOD 2/2 and control wild-type hearts hybridized with ANF antisense RNA. In the wild-type heart, ANF expression was mostly confined to the atria with only some residual expression in the left ventricle, whereas ANF expression was present in all heart chambers of SOD deficient hearts ( Figure 2D) . The atrial expression level was significantly higher in SOD 2/2 tissue compared with wild-type control ( Figure 2C ).
Lack of compensatory activation of antioxidative enzymes in tissues of manganese-dependent superoxide dismutase heterozygous mice
In the further course of this work, we examined the impact of a prolonged decrease of MnSOD expression on heart physiology. We detected a reduction of MnSOD protein expression and its enzymatic activity by 20-30% in heterozygous TRE/ SOD animals ( Figure 1F and Table 1 ), indicating a compensatory increase of the activity of the functional allele and/or a stabilization of the MnSOD mRNA or protein. To learn more about a possible compensatory increase of other major antioxidant enzymes, we analysed their activity in liver, heart, and brain of heterozygous animals and wild-type control tissues. Most enzymes did not exhibit significant changes between wild-type and MnSOD heterozygous tissues (Table 1 ) with the exception of cytosolic CuZnSOD. Surprisingly, we found a decrease of the activity of cytosolic CuZnSOD in the heart of MnSOD heterozygotes (Table 1) , which, however, lacked statistical significance due to the high variability of ZnCuSOD activity (P . 0.05, Table 1 ).
Partial manganese-dependent superoxide dismutase deficiency leads to a decreased heart performance
The reduced MnSOD activity, which was not compensated by other antioxidative enzymes, will lead to a higher level of superoxide anions. Eventually, the resulting accumulation of reactive oxygen species (ROS) will result in the oxidative damage of various macromolecules (Supplementary material online, Figure S1 ). 22 To examine the effects of prolonged oxidative damage on the function of the heart, TRE/SOD heterozygous (n ¼ 9) and wild-type control mice (n ¼ 6) were examined by echocardiography at the age of 6 months. Echocardiographic measurements revealed an impaired left ventricular function of MnSOD þ/2 mice ( Table 2 ). This was additionally indicated by the decrease of fraction shortening (FS) by 26% and fractional area change (FAC) by 21% in MnSOD þ/2 mice compared with wild-type controls ( Table 2 ). In addition, the ejection fraction (EF) was decreased in heterozygotes by 18% ( Table 2) . These alterations were accompanied by a 21% increase in left ventricle internal diameter in systole in MnSOD þ/2 animals, whereas the left ventricle internal diameter in diastole (LVIDD) was not changed significantly ( Table 2) .
Hypertrophy, fibrosis, and necrosis in MnSOD 1/2 hearts
We assumed that the deterioration of parameters of heart function is accompanied by morphological changes in the myocardium of heterozygous animals and hence performed a histological analysis of hearts of 5-month-old animals. Immunofluorescent staining of proteins located within intercalated disks and/or membranes associated proteins such as plakoglobin 27 revealed the presence of hypertrophic cardiomyocytes in the myocardium of MnSOD þ/2 mice ( Figure 3A  and B) . Size quantification revealed a mean diameter of 18.25 + 5.12 and 13.62 + 5.12 mm for the MnSOD þ/2 and wild-type cardiomyocytes, respectively (Supplementary material online, Figure S2) . Further staining for the extracellular matrix protein collagen VI did also indicate increased fibrosis ( Figure 3C and D) . Finally, we detected the presence of necrotic cells in the myocardium of MnSOD þ/2 mice by staining for complement 9, 28 whereas wild-type myocardium was devoid of any necrotic cells ( Figure 3E and F ) . In the MnSOD þ/2 myocardium, we accounted 1-2 necrotic cells per 1000 counted cardiomyocytes, whereas no C-9 positive cells were found in 8000 wild-type cardiomyocytes.
Increased susceptibility of MnSOD
1/2 heart to doxorubicin treatment
To investigate whether a reduced activity of MnSOD affects stress resistance mechanisms, we treated MnSOD heterozygous and control mice with 15 mg/kg of doxorubicin over a time period of 2 weeks. Mice implanted with osmotic pumps filled with vehicle solution (PBS) were used as controls. The myocardium of doxorubicin treated mice was examined for signs of increased apoptosis, senescence, and degeneration. As illustrated in Figure 4 , wild-type animals were able to cope efficiently with these challenges thereby preserving tissue integrity. In contrast, the myocardium of MnSOD heterozygous mice was more susceptible to doxorubicin treatment. We detected a significant increase of the number of apoptotic cardiomyocytes in the wall of the left ventricle ( Figure 4A and S) . Similarly to MnSOD homozygous newborn hearts, the apoptotic cells were confined to the superficial layer of the left ventricle where clusters of apoptotic TUNEL-positive cells were frequently observed. Such apoptotic clusters were absent in the control myocardium ( Figure 4B and T ). The same was true for wild-type and heterozygous mice after implantation of vehicle filled pumps (data not shown). In all experiments, levels of apoptosis were correlated with an increased caspase 3 expression ( Figure 5A ). In addition, doxorubicin treatment led to further increase of the number of necrotic cells (11 + 2 C-9 positive cells per 1000 when compared with 1-2 necrotic cells in untreated MnSOD þ/2 cardiomyocytes, Figure 3E and data not shown). To prove whether MnSOD mimetica could revert the apoptotic response MnTBAP was administered together with the doxorubicin treatment. Interestingly, at least partial protection was achieved ( Figure 4E and W, Figure 5A and D). Furthermore, doxorubicin induced necrosis could be almost completely prevented (data not shown). Administration of doxorubicin did also lead to the induction of senescence in MnSOD heterozygotes, whereas no senescent cells were found in control animals ( Figure 5B) . Interestingly, the presence of SA-b-Gal positive cells was mostly confined to vascular smooth muscle and endothelial cells ( Figure 5B ). In addition, a weak SA-b-Gal staining was observed in the mitral valve ( Figure 5B) . No SA-b-Gal cells were found in other parts of the heart (data not shown). Hearts of wild-type control animals, which had also been treated with doxorubicin, completely lacked SA-b-Gal positive cells ( Figure 5B and data not shown). Finally, doxorubicin treatment led to a significant increase of ANF expression indicating that exposure to doxorubicin induced degenerative processes in MnSOD heterozygous hearts ( Figure 5C and D) . Expression of ANF in wild-type control animals was confined to the atria. No ANF signals were present in other parts of wild-type hearts suggesting resistance against doxorubicin treatment ( Figure 5C and data not shown). Notably, MnTBAP could efficiently prevent the higher ANF expression caused by doxorubicin exposure ( Figure 5D ).
Discussion
In contrast to currently available conditionally active MnSOD strains, the TRE/SOD mouse allows not only inactivation of MnSOD expression but also its re-activation after defined time periods. The strain provides a versatile tool to investigate the role of MnSOD in specific tissues under defined experimental conditions as for example ischaemia/reperfusion, caloric restriction, and other types of cellular stress. Homozygous TRE/SOD mice showed an early onset of mortality (around 2 weeks postnatal) associated with decreased body weight and size, which is in full agreement with previous reports using conventional MnSOD knockout animals.
1-3 Thus, the replacement of the endogenous promoter by TREs completely uncoupled the expression of MnSOD cDNA from internal stimuli but allowed specific regulation by exogenously supplied doxycyclin. Our analysis of MnSOD deficient mice concentrated on the heart, since heart failure has been postulated to be the primary cause of death of MnSOD knockout animals. It has been claimed that the increased oxidative burden in MnSOD mutants resulted in enhanced rate of apotosis of cardiomyocytes and eventually in heart failure. However, hearts isolated from neonatal (P3) TRE/SOD homozygous mice displayed only a low-level of apoptosis in the subepicardial layer of the left ventricle, whereas deeper layers of the myocardium were devoid of apoptotic cells. Cultured cardiomyocytes, in contrast, seem more susceptible to ROS-induced cell death, which is not surprising considering the additional stress evoked by isolation and in vitro culture. 23 It is noteworthy that our observations are in agreement with a recent report, which describes the lack of apoptosis in the myocardium of 15-week-old mice, in which the MnSOD gene was specifically deleted in heart and skeletal muscle. 15 However, our finding of a strong up-regulation of ANF expression in MnSOD deficient neonatal hearts supports numerous originally described pathological changes. 1, 3 It seems likely that the increase of ANF expression results from haemodynamic overload caused by impaired function of the heart, abnormal tissue architecture, and other pathogenic stimuli including increased oxidative stress. [29] [30] [31] Despite the potential clinical relevance and the utilization of heterozygous mutant MnSOD mice in pharmacological/ toxicological research 32 only few attempts have been made to determine the effects of a reduction of MnSOD activity on the function of the heart. For example, Sam et al. 33 reported a markedly reduced MnSOD protein and its enzymatic activity by 60% in failing human myocardium. Furthermore, human patients with reduced MnSOD activity show an increased incidence of dilative cardiomyopathy. 34 Mutations within the MnSOD mitochondrial targeting sequence (Ala16Val), which correlates with dilated cardiomyopathy, lead to an 25% decrease of MnSOD activity due to the impaired MnSOD import to the mitochondria and lower mRNA stability. 35 Interestingly, we found that a 30% reduction in MnSOD activity impairs the function of the heart. The decline of normal heart functions became manifest in 6-month-old MnSOD heterozygous mice and was accompanied by a decrease in EF, FS, FAS, and an increase in left ventricle diameter in systole. No differences were evident in LVIDD and in the thickness of heart wall. The observed changes caused by decreased MnSOD activity are characteristic for a mild form of dilated cardiomyopathy, which advances with age thereby resembling the phenotype of human patients carrying mutations within the MnSOD mitochondrial targeting sequence. The deterioration of functional parameters of heterozygous MnSOD hearts went along with enhanced fibrosis, hypertrophic cardiomyocytes, and occasional necrosis.
Since our MnSOD heterozygous animals responded to the doxorubicin treatment by an increase of the number of apoptotic cells within the epicardium and ectopic expression of ANF, we reason that diminished MnSOD activity leads to a higher susceptibility to different stressors especially oxidative stress. MnSOD heterozygous animals do not only show a higher vulnerability to stressors but were also characterized by increased fibrosis and hypertrophy in the myocardium, which might impair cardiac function. Furthermore, we observed increased numbers of senescent cells in the vascular smooth muscle cell layer and in endothelial cells of cardiac vessels. Apparently some tissues and cells, which are particularly exposed to superoxide anions such as vessels and the myocardium, require the optimal activity of MnSOD to prevent cellular damage. Any further increase in the concentration of superoxide anions as caused by the doxorubicin metabolism will lead to further deterioration of cellular integrity. Increased superoxide levels will also contribute to the conversion of NO to peroxynitrite in endothelial cells, which will have harmful effects on vessels. In addition, the conversion of NO to peroxynitrite will decrease the bioavailability of NO; a scenario that promotes endothelial dysfunction and vascular disorders. 13, [36] [37] [38] Most importantly, we could demonstrate a partial reversion of the doxorubicin caused damage by treatment with MnSOD mimeticum, MnTBAP. This finding strongly supports the possible beneficial effects of antioxidative pharmacological treatments in human conditions. In summary, our study describes a new transgenic model, which facilitates refined studies to understand the role of MnSOD in the cardiovascular system. We have demonstrated that even a relatively small decrease in MnSOD activity impaired the function of the heart. On the basis of our findings, we postulate that a reduction of MnSOD activity will contribute to vascular senescence.
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